Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study.
about
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosisTreatment strategies for multiple sclerosis: When to start, when to change, when to stop?Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French CenterThe Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational studyFingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis.Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.A longitudinal real-life comparison study of natalizumab and fingolimod.
P2860
Q26771635-0F1BD817-EA94-4699-BD01-784A1A44FC77Q26798434-91672927-F8B6-4427-94AD-CE9524BF6F76Q30815289-2CACEB70-6176-474D-90AE-9DEFF42848D7Q33614909-21201CEA-331C-43A3-B110-4C2AC32E6090Q33639041-2D94455B-5CFD-49ED-853C-9EE164054745Q36148189-46D8F645-7B19-4581-AF17-9DDF16BE11DBQ36607690-8F235348-3DC5-43F6-B99F-CAD8DA8CF715Q38606914-6A807469-49C3-4291-B655-D15158CD8A14Q39732691-5D692A73-A134-4364-BF68-4270CDB53588Q48650575-4494E698-6F96-4993-98E9-53CCC54F5B46
P2860
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Are natalizumab and fingolimod ...... practice observational study.
@en
Are natalizumab and fingolimod ...... practice observational study.
@nl
type
label
Are natalizumab and fingolimod ...... practice observational study.
@en
Are natalizumab and fingolimod ...... practice observational study.
@nl
prefLabel
Are natalizumab and fingolimod ...... practice observational study.
@en
Are natalizumab and fingolimod ...... practice observational study.
@nl
P356
P1433
P1476
Are natalizumab and fingolimod ...... practice observational study.
@en
P2093
Luciano Deotto
Maria Rachele Bianchi
P304
P356
10.1159/000361044
P577
2014-09-06T00:00:00Z